Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2010
03/31/2010CN101683593A Nano-emulsions and method of producing them, and their use
03/31/2010CN101683532A Ophthalmic compound medicinal preparation containing hyaluronic acid or sodium hyaluronate
03/31/2010CN101683527A Compound preparation for treating cold and preparation method thereof
03/31/2010CN101683525A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
03/31/2010CN101683524A Method for preparing bacterial ghost by combination of antibacterial peptide and ultrahigh pressure and application thereof
03/31/2010CN101683522A Novel albumin-free factor viii formulations
03/31/2010CN101683521A Human eryth ropoietin liposome
03/31/2010CN101683510A Chinese medicine patch for treating cold and pain and method for producing the same
03/31/2010CN101683492A Patch for treating facioplegia and method for producing the same
03/31/2010CN101683412A Chinese medicine patch for treating children's bronchus asthma and method for producing the same
03/31/2010CN101683394A Externally applied patch for treating phlebitis and method for producing the same
03/31/2010CN101683388A Patch applied on navel for treating enuresis of children and method for producing the same
03/31/2010CN101683375A Chinese medicine patch for treating rheumatism and impediment pain and method for producing the same
03/31/2010CN101683374A Patch for treating disc herniation and method for producing the same
03/31/2010CN101683367A Method for preparing emulsified medicinal composition containing oleum fructus bruceae
03/31/2010CN101683361A In-stomach floating type sustained-release pellet prepared from traditional Chinese medicine compound preparations
03/31/2010CN101683333A Method for preparing atorvastatin calcium adsorbate and relevant solvate thereof
03/31/2010CN101683326A Super concentrated natural allicin tablets with quick-acting antibiosis, anti-inflammation and antivirus and preparation method thereof
03/31/2010CN101683325A Cydiodine buccal tablets and preparation method thereof
03/31/2010CN101683316A Temperature responsive bio-adhesive in situ gel sustained-release preparation for vagina
03/31/2010CN101683315A Preparation method of composite hyaluronic acid-sulfadiazine silver gel
03/31/2010CN100596332C Medicine-carrying contact lens and preparation method thereof
03/31/2010CN100596280C Film for treating oral ulcer and preparation method thereof
03/30/2010US7687569 adhesion promoters comprising polyesters composed of alpha-, beta-unsaturated dicarboxylic acids and dicidol mixtures or isomers, and diluents comprising polymerizable solvents containing acrylic monomers, used on metallic or mineral substrates, wood, paper, plastic, ceramic or glass
03/30/2010US7687483 Phosphorus compounds used for improving permeability of drugs such as anticarcinogenic agents to biological barriers; drug delivery
03/30/2010US7687480 Phosphonate compounds
03/30/2010US7687467 for treatment of attention deficit hyperactivity disorder, narcolepsy; bioavailability
03/30/2010US7687466 Abuse-resistant amphetamine prodrugs
03/30/2010US7687458 Pharmaceutical compositions of hydrophobic compounds
03/30/2010US7687455 comprising fluorocarbon vector-antigen, immunogens; vaccines, immunotherapy
03/30/2010US7687453 Method for administering insulin to the buccal region
03/30/2010US7687087 Extracting oil seed protein seed meal for use in fortification of processed foods, emulsification of oils, body formers in baked goods and foaming agents in products which entrap gases
03/30/2010US7687083 Pharmaceutical compositions comprising old man's beard (Usnea barbata) and St. John's wort (Hypericum perforatum) and their use
03/30/2010US7687080 Treatment of neuropathy
03/30/2010US7687079 Methods of treating ileus
03/30/2010US7687074 Prevent adhesion of pathogens; mixture containing fatty acid, or glycerides thereof
03/30/2010US7687073 Providing particles of at least one active material selected from corticosteroids, beta -agonists, anticholinergics, leukotriene antagonists and inhalable proteins or peptides and a solid binder, agglomerating active particles and binder
03/30/2010US7687071 acrylic acid-methacrylic acid copolymers; bioavailability
03/30/2010US7687068 Particulate vitamin composition
03/30/2010US7687064 Methods and compositions associated with administration of an extract of Ganoderma lucidum
03/30/2010US7687054 Sustained release; drug delivery
03/30/2010CA2472237C Multi-stage oral drug controlled-release system
03/30/2010CA2472028C Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
03/30/2010CA2467611C Azithromycin dosage forms with reduced side effects
03/30/2010CA2457250C Oily thixotropic formulations
03/30/2010CA2442673C Cactaceae-based formulation having the property of fixing fats, and method for obtaining same
03/30/2010CA2438651C Mucoadhesive, disintegratable medicinal preparation for active substance administration in veterinary and human medicine
03/30/2010CA2409665C Novel composition
03/30/2010CA2380673C Compositions comprising modafinil for treatment of attention deficit hyperactivity disorder
03/30/2010CA2378855C Titanium derived compounds, preparation and use thereof
03/30/2010CA2374044C Sports drink comprising lactobacilli
03/30/2010CA2362277C Spontaneously dispersible n-benzoyl staurosporine compositions
03/30/2010CA2356404C Method for accelerating the rate of mucociliary clearance
03/30/2010CA2355860C Dosage forms comprising porous particles
03/30/2010CA2263765C Methods for the production of protein particles useful for delivery of pharmacological agents
03/30/2010CA2241604C Mesothelium antigen and methods and kits for targeting it
03/25/2010WO2010034019A1 Transdermal drug delivery using an osmolyte and vasoactive agent
03/25/2010WO2010033832A2 Estriol formulations
03/25/2010WO2010033598A2 System and method for utilizing microbubbles and liposomes as viral sequestering agents
03/25/2010WO2010033528A1 Stabilized pharmaceutical sub-micron suspensions and methods of forming same
03/25/2010WO2010033239A1 Polymer conjugates of biphalin peptides
03/25/2010WO2010033227A1 Polymer conjugates of thymosin alpha 1 peptides
03/25/2010WO2010033226A1 Oligomer-protease inhibitor conjugates
03/25/2010WO2010033224A1 Polymer conjugates of kiss1 peptides
03/25/2010WO2010033223A1 Polymer conjugates of opioid growth factor peptides
03/25/2010WO2010033222A2 Polymer conjugates of ziconotide peptides
03/25/2010WO2010033221A1 Polymer conjugates of protegrin peptides
03/25/2010WO2010033220A2 Modified therapeutics peptides, methods of their preparation and use
03/25/2010WO2010033218A1 Polymer conjugates of osteocalcin peptides
03/25/2010WO2010033217A1 Polymer conjugates of cd-np peptides
03/25/2010WO2010033216A1 Polymer conjugates of nesiritide peptides
03/25/2010WO2010033215A2 Polymer conjugates of aod-like peptides
03/25/2010WO2010033207A1 Polymer conjugates of therapeutic peptides
03/25/2010WO2010033205A1 Polymer conjugates of v681-like peptides
03/25/2010WO2010033204A2 Polymer conjugates of c-peptides
03/25/2010WO2010033195A1 Pegylated opioids with low potential for abuse
03/25/2010WO2010033042A1 A process for the preparation of a multi-compartment lipid implant
03/25/2010WO2010033022A1 Method for the preparation of a controlled release system
03/25/2010WO2010032510A1 Novel branched glucan, method for producing the same, and use of the same
03/25/2010WO2010032434A1 Composite organic compound powder for medical use, method for producing same and suspension of same
03/25/2010WO2010032220A1 Stable liquid antibody formulation
03/25/2010WO2010031866A1 Lactose and cellulose-based tableting aid
03/25/2010WO2010031346A1 Freeze-dried preparation of tetrodotoxin and the producing method thereof
03/25/2010WO2010031185A1 Treating cancer stem cells using targeted cargo proteins
03/25/2010WO2010031168A1 HETERO-MULTIVALENT BINDING AGENTS FOR MEMBERS OF THE TGFβ SUPERFAMILY
03/25/2010WO2010014915A3 Novel peptides for use in transfection
03/25/2010WO2010006454A3 Functionalized polypeptides
03/25/2010WO2010006200A3 Triggered release of drugs from polymer particles
03/25/2010WO2010005740A3 Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
03/25/2010WO2010005637A3 Electrostatically charged multi-acting nasal application, product, and method
03/25/2010WO2010002450A3 Micelles for delivery of nitric oxide
03/25/2010WO2009158256A3 Transdermal delivery apparatus and method
03/25/2010WO2009155335A3 Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization
03/25/2010WO2009154396A3 Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release
03/25/2010WO2009127974A3 Pharmaceutical formulation for treating cardiovascular disease
03/25/2010WO2009121759A3 Use of pegylated igf-i variants for the treatment of neuromuscular disorders
03/25/2010WO2009114703A3 Combination therapy for the treatment of cancer
03/25/2010WO2009106555A3 Sterilized sucralfate gel
03/25/2010WO2009099679A3 Treatment of disease conditions via administration of dna repair enzyme
03/25/2010WO2008095004A3 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
1 ... 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 ... 1712